Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
22,332,926
-
Shares change
-
-727,315
-
Total reported value, excl. options
-
$1,506,651,537
-
Value change
-
-$37,805,529
-
Put/Call ratio
-
196%
-
Number of buys
-
82
-
Number of sells
-
-80
-
Price
-
$67.46
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2021
220 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2021.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,332,926 shares
of 48,932,355 outstanding shares and own 45.6% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2,614,145 shares), IRIDIAN ASSET MANAGEMENT LLC/CT (2,315,263 shares), BlackRock Inc. (2,120,754 shares), RA CAPITAL MANAGEMENT, L.P. (1,655,447 shares), RTW INVESTMENTS, LP (1,616,497 shares), ALETHEA CAPITAL MANAGEMENT, LLC (1,010,945 shares), PRICE T ROWE ASSOCIATES INC /MD/ (748,247 shares), Nuveen Asset Management, LLC (658,334 shares), STATE STREET CORP (639,757 shares), and CITADEL ADVISORS LLC (569,805 shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.